Buzz Stocks: GE, SAGE Therapeutics, and AngloGold Ashanti

Stocks are mixed in early trading, as traders await the latest economic reports and keep an eye trained on Greece.  In company news, today's stocks to watch include Dow component General Electric Company (NYSE: GE), pharmaceutical firm SAGE Therapeutics Inc (NASDAQ: SAGE), and mining firm AngloGold Ashanti Limited (ADR) (NYSE: AU).

• GE is down 0.2% at $27.19, after agreeing to sell its Antares unit to Canada's largest pension fund. The deal carries a price tag of $12 billion. General Electric Company remains 7.5% higher year-to-date, and since peaking at $28.68 in mid-April, has been consolidating atop its 10-week moving average.

• SAGE rocketed to an all-time peak of $89, and was last seen 17.7% higher at $88.43, thanks to positive data from a drug trial. The company's exploratory treatment SAGE-547 showed positive results in four women suffering from postpartum depression. Even before today's data, analysts were in SAGE Therapeutics Inc's bullish corner, as all five brokerage firms consider the equity a "strong buy."

• AU is 9.5% higher at $9.55, after Newmont Mining Corp (NYSE: NEM) agreed to purchase AU's Cripple Creek & Victor gold mine in Colorado. The price tag for the acquisition totals $820 million in cash along with future considerations. AU is now poised to close above its 10-day moving average for the first time since May 14. Prior to today, AngloGold Ashanti Limited's 14-day Relative Strength Index (RSI) fell to 23 -- in oversold territory, suggesting a bounce may have been in the cards.